News

Buy HealthCare Global Enterprises Ltd For Target Rs.370 - ICICI Direct Margins continue to improve; outlook better… About the stock: HCG operates one of the largest private cancer care networks in India with end-to-end solutions available under a single corporate entity. Owing to exclusive agreement with vendors, HCG procures equipment on a deferred payment basis. Milann offers seven fertility centres in India. * HCG network has 22 comprehensive cancer centres (one in Kenya), four multi-specialty hospitals. HCG India, capacity beds: 1944; 1702 opera...
Buy HealthCare Global Enterprises Ltd For Target Rs.370 - ICICI Direct
Buy HealthCare Global Enterprises Ltd For Target Rs.370 - ICICI Direct
Source: ICICI Direct Ltd
15/12/2022 1:46:29 PM
Add HealthCare Global Enterprises Ltd For Target Rs.339 - ICICI Securities We met the management of HealthCare Global Enterprises (HCG) to discuss the company’s performance and strategy. Highlights: ? HCG reiterates its focus on: i) cost rationalisation, ii) talent upgrade, and iii) digital transformation. It intends to stick to its core competency area of oncology and has no plans to venture into other therapy areas. ? International patients: i) Alongside Bangalore hospital, Mumbai and Kolkata too are witnessing good inflow of patients. Proximity to Ban...
Add HealthCare Global Enterprises Ltd For Target Rs.339 - ICICI Securities
Add HealthCare Global Enterprises Ltd For Target Rs.339 - ICICI Securities
Source: ICICI Securities
13/09/2022 10:26:25 AM
Buy HealthCare Global Enterprises Ltd For Target Rs.339 - ICICI Securities Management meet highlights We met the management of HealthCare Global Enterprises (HCG) to discuss the company’s performance and strategy. Highlights: * HCG reiterates its focus on: i) cost rationalisation, ii) talent upgrade, and iii) digital transformation. It intends to stick to its core competency area of oncology and has no plans to venture into other therapy areas. * International patients: i) Alongside Bangalore hospital, Mumbai and Kolkata too are witnessing good inflow...
Buy HealthCare Global Enterprises Ltd For Target Rs.339 - ICICI Securities
Buy HealthCare Global Enterprises Ltd For Target Rs.339 - ICICI Securities
Source: ICICI Securities Ltd
8/09/2022 11:22:42 AM
HCG moves up on entering into Business Transfer Agreement with Radiant Hospital Services HealthCare Global Enterprises is currently trading at Rs. 298.40, up by 7.80 points or 2.68% from its previous closing of Rs. 290.60 on the BSE. The scrip opened at Rs. 297.00 and has touched a high and low of Rs. 299.20 and Rs. 287.90 respectively. So far 9386 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 312.80 on 18-Apr-2022 and a 52 week low of Rs. 201.80 on 24-Jun-2021. Last one week high and low of the ...
HCG moves up on entering into Business Transfer Agreement with Radiant Hospital Services
HCG moves up on entering into Business Transfer Agreement with Radiant Hospital Services
Source: Accord Fintech
24/06/2022 11:10:38 AM
Add HealthCare Global Enterprises Ltd For Target Rs.292 - ICICI Securities Management meet highlights: * According to management, oncology will remain a key focus area for the company. * Role of top management is focusing on improving performance and efficiency * Mr Raj Gor, with his extensive experience, is focusing on improving the company’s operational and financial efficiency. * Dr Ajai Kumar is working on research and technical parameters like tumors and genomics on recurrence, improving the processes, and working on AI technology to impr...
Add HealthCare Global Enterprises Ltd For Target Rs.292 - ICICI Securities
Add HealthCare Global Enterprises Ltd For Target Rs.292 - ICICI Securities
Source: ICICI Securities
11/12/2021 9:33:59 AM
Add HealthCare Global Enterprises Ltd For Target Rs.264 - ICICI Securities Strong growth recovery HealthCare Global Enterprises’ (HCG) Q1FY22 performance was better than our estimates driven by continued sequential recovery in the oncology hospital segment which recorded revenue growth of 9.6% QoQ. Coupled with controlled cost EBITDA margin beat our estimates by 190bps to 15.9% (I-Sec: 14.0%). We believe that the business has normalised and this growth trend will continue. Recent capital infusion has removed the key overhang of high leverage with repayme...
Add HealthCare Global Enterprises Ltd For Target Rs.264 - ICICI Securities
Add HealthCare Global Enterprises Ltd For Target Rs.264 - ICICI Securities
Source: ICICI Securities
15/10/2021 9:52:31 AM
Hold Healthcare Global Enterprises Ltd For Target Rs.240 - ICICI Direct Recovery in Q1 with better margins… About the stock: HCG operates one of the largest private cancer care networks in India with end-to-end solutions available under a single corporate entity. This consists of 22 comprehensive cancer centres that provide a single point destination for complete cancer care. * Most centres are on a lease or rental basis with some in partnership with local doctors or hospitals * Owing to exclusive agreement with vendors, HCG procures equipment on ...
Hold Healthcare Global Enterprises Ltd For Target Rs.240 - ICICI Direct
Hold Healthcare Global Enterprises Ltd For Target Rs.240 - ICICI Direct
Source: ICICI Direct
14/10/2021 10:14:12 AM
Add HealthCare Global Enterprises Ltd For Target Rs. 206 - ICICI Securities Growth momentum to continue HealthCare Global Enterprises’ (HCG) Q4FY21 performance was broadly inline with our estimates driven by continued sequential recovery in the oncology hospital segment revenues that grew 8.8% QoQ. However, higher than expected costs suppressed EBITDA margin to 13.2% (I-Sec: 14.5%). We expect the recovery trend to continue and normalcy to be achieved by H2FY22E. Recent capital infusion has removed the key overhang of high leverage with repayment of debt from...
Add HealthCare Global Enterprises Ltd For Target Rs. 206 - ICICI Securities
Add HealthCare Global Enterprises Ltd For Target Rs. 206 - ICICI Securities
Source: ICICI Securities
15/07/2021 11:16:03 AM